Latest filing published 15 Oct 2020 for Quinstreet, INC, €266k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 17 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +228.2%Entry US$2.98 · Close at T+365 US$9.78
- +10.2%Entry US$4.53 · Close at T+365 US$4.99
- -28.8%Entry US$8.44 · Close at T+365 US$6.01
- -23.1%Entry US$10.80 · Close at T+365 US$8.30
- -19.9%Entry US$11.27 · Close at T+365 US$9.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gregory P. Sands: trading record in brief
Filings by Gregory P. Sands span 6 companies, the busiest being Mattersight Corp, Quinstreet, Inc and Corcept Therapeutics Inc. We count 181 filings; the first trade dates from 8 February 2006 and the latest from 13 October 2020.
The open-market side counts 102 purchases for €6.5M alongside 6 sales for €7.0M. Netting one side against the other leaves €461k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 14 share grants and 10 option exercises.
Half of the purchases are above €24k and half below. Ninety days after publication, 17 purchases show a median change of +8.1%, with the price up in 65% of them. This is a record of the past, not a forecast.
On 15 October 2020 came the latest disclosure, an option exercise for €266k in Quinstreet, Inc. The most recent open-market purchase was published on 21 November 2016, 3,639 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gregory P. Sands
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$15.6078.5% of flowCommon StockSEC:0001117297-20-000075:0
- 4,996 shares@ US$9.237.4% of flowCommon StockSEC:0001117297-20-000071:0
- 7,100 shares0Common StockSEC:0001117297-20-000067:0
- 5,302 shares@ US$7.016.5% of flowCommon StockSEC:0001117297-20-000036:0
- 6,578 shares0Common StockSEC:0001117297-19-000083:0
- 5,519 shares@ US$6.301.4% of flowCommon StockSEC:0001117297-19-000058:0
- 25,000 shares@ US$6.906.9% of flowCommon StockSEC:0001117297-19-000056:0
- 6,785 shares@ US$16.273.7% of flowCommon StockSEC:0001117297-18-000084:0
- 14,912 shares@ US$15.817.8% of flowCommon StockSEC:0001117297-18-000084:1
- 5,000 shares@ US$15.812.6% of flowCommon StockSEC:0001117297-18-000084:2
- 35,000 shares@ US$15.9718.6% of flowCommon StockSEC:0001117297-18-000084:3
- 25,000 shares@ US$11.269.3% of flowCommon StockSEC:0001117297-18-000074:0
- 25,000 shares@ US$9.247.7% of flowCommon StockSEC:0001117297-18-000074:1
- 5,345 shares@ US$8.561.5% of flowCommon StockSEC:0001117297-18-000074:2
- 7,733 shares0Common StockSEC:0001117297-18-000071:0
- 75,860 shares@ US$5.5813.7% of flowCommon StockSEC:0001117297-18-000056:0
- 139,643 shares@ US$3.5215.2% of flowCommon StockSEC:0001117297-18-000017:0
- 13,888 shares0Common StockSEC:0001117297-17-000039:0
- 10,000 shares@ US$2.640.9% of flowCommon StockSEC:0001117297-16-000096:0Canonical exit: 19 Feb 2017 (T+90)
- 33,783 shares0Common StockSEC:0001117297-16-000087:0
- 10,000 shares0Common StockSEC:0001117297-15-000043:0
- 12,000 shares@ US$4.03Common StockSEC:0001117297-14-000099:0Canonical exit: 5 Feb 2015 (T+90)
- 10,000 shares0Common StockSEC:0001117297-14-000083:0
- 10,000 shares0Common StockSEC:0001117297-13-000047:0
- 30,654 shares0Common StockSEC:0001225208-11-026238:0
25 of 129 declarations
